ADS032 ADS032 is actually a dual inhibitor of NLRP1 and NLRP3 that swiftly, reversibly and stably inhibits inflammasome formation and lowers NLPR1 and NLRP3 activation of human-derived macrophages and bronchial epithelial cells to secrete and mature IL-1β and TNF-α, and minimizes NLRP3-induced ASC speck formation. In March 2020, Inflazome declared https://edend332pbm6.dailyblogzz.com/profile